The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefepime Mixture With Arginine Drug Master File in Japan (Cefepime Mixture With Arginine JDMF) empowers Cefepime Mixture With Arginine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefepime Mixture With Arginine JDMF during the approval evaluation for pharmaceutical products. At the time of Cefepime Mixture With Arginine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefepime Mixture With Arginine suppliers with JDMF on PharmaCompass.